Monoclonal antibodies in the treatment of chronic lymphocytic leukemia

By Liu Nina   O’Brien Susan  

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 297-304

Humana Press, Inc

Access to resources Recommend Favorite

Potential New Agents for Chronic Lymphocytic Leukemia Treatment

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 9, 2010-11 ,pp. : 666-682

Bentham Science Publishers

Access to resources Recommend Favorite

Refractory Chronic Lymphocytic Leukemia: Prognosis and Treatment Options

By Wierda William G.   Keating Michael J.   O'Brien Susan  

American Journal of Cancer, Vol. 3, Iss. 3, 2004-01 ,pp. : 163-178

Adis International

Access to resources Recommend Favorite

New and Repositioning Approaches to the Treatment of Chronic Lymphocytic Leukemia(

By  

International Journal of Cancer Research and Prevention, Vol. , Iss. , 2017-01 ,pp. : 67-100

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-CELL chronic lymphocytic leukemia

By Cavalli-Björkman Nina   Ösby Eva   Lundin Jeanette   Kalin Mats   Österborg Anders   Gruber Astrid  

Medical Oncology, Vol. 19, Iss. 4, 2002-12 ,pp. : 277-280

Humana Press, Inc

Access to resources Recommend Favorite